# Commission Implementing Decision (EU) 2016/1250 of 12 July 2016 pursuant to Directive 95/46/EC of the European Parliament and of the Council on the adequacy of the protection provided by the EU-U.S. Privacy Shield (notified under document C(2016) 4176) (Text with EEA relevance) (revoked), Division g: Key-coded Data

Extent: E+W+S+N.I.
Status: repealed

Invariably, research data are uniquely key-coded at their origin by the principal investigator so as not to reveal the identity of individual data subjects. Pharmaceutical companies sponsoring such research do not receive the key. The unique key code is held only by the researcher, so that he or she can identify the research subject under special circumstances (e.g., if follow-up medical attention is required). A transfer from the EU to the United States of data coded in this way would not constitute a transfer of personal data that would be subject to the Privacy Shield Principles.

---
Source: https://www.legislation.gov.uk/eudn/2016/1250/annex/II/division/III/division/14/division/g (the official version)
Page: https://openlegislation.uk/eu-decision-2016-1250/annex-II/division-III/division-14/division-g
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.